Preclinical & Early Phase Research

Early-phase research is a strategy-driven first step in the development of new drugs and medical devices. In drug development, pre-clinical studies are designed to provide detailed information on dosing and toxicity levels. This phase of development allows for the selection of the best novel agents to enter the clinical trial phase and to minimize failure in development. Pre-clinical evaluation is highly important for the development of innovative medical devices, as safety and efficacy testing enable the design of studies that fulfill regulatory requirements. DIA provides a forum, network, and resources for facilitating collaboration and insights exchange for professionals involved in pre-clinical and early-phase research..